Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by EquityInveston Feb 17, 2018 8:08pm
150 Views
Post# 27578940

RE:RE:RE:5

RE:RE:RE:5I agree with HansonLockyer's post.

The MJ sector has not lost investors interest.  The share price of the big 3 will not significantly downtrend as there is no question that legalization will happen. 

However, the uncetainty stemming from Senate's delay (i.e., possible further delay if not approved on 3rd reading by June 7th due to 2-months Senate break) is holding back sp. 

The Market is impatient and the legalization delay means additional risks such as the negative effect of any interest rate hike on the sector's ability to service its debts, inability of the sector to achieve optimal sales due to regulatory constraints, etc.  

The delay and the US's current stand on MJ are also preventing institutional investors as well as big Pharma, Tobacco, Beverage companies from investing in the sector.  The latter will skyrocket the sector's sp, we just need to be patient.

GLTA.

____________________
HansonLockyer wrote:
Hard to call it a sector rotation because I don't think there is a lack of interest but more like confusion in Canada and the USA. Aurora's master plan is intact and progressing so I don't worry too much about this one or WEED.  I therefore, as an expert analyst in the political excrement industry believe this to be a classic TEMPORARY lull until the SESSIONS are over and done with. So dare I say July at the latest or unless there is Earth shattering news like Ivana (Ivanka) smoking a joint in public we will be range bound.  Charts indicate this is just about in oversold and its safe to acumulate.

Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.acb&postid=27578828#8kTRlePUe6FSmmWO.99
Bullboard Posts